RECENT NEWS

Paul Ladestein, Director, Commercial Operations Northern Europe at Beckman Coulter, tells PiP about his company’s new Dxl 9000 Analyser, on show for the first time in the UK at IBMS Congress, as well as explaining how Beckman Coulter is bringing innovation into its customers’ laboratories.

Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, have unveiled a multi-year joint development collaboration to develop new clinical tests for diseases and improve patient care.

The World Health Organization (WHO) has released a new publication listing key regulatory considerations on artificial intelligence (AI) for health. The publication emphasises the importance of establishing AI system safety and effectiveness, rapidly making appropriate systems available, and fostering dialogue among stakeholders.

Roche has announced that its Elecsys IL-6 immunoassay has become the first interleukin-6 (IL-6) test to have a certified claim for use in diagnosis of neonatal sepsis, in countries accepting the CE Mark.

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives.

Revvity and genomic sequencing firm Element Biosciences have announced a collaboration to introduce workflow solutions that save time and effort required for genomic analysis of samples. Element Biosciences is the developer of the AVITI System, an innovative and emerging genomic sequencing platform.

See David Wells give Pathology in Practice Editor Andy Myall an update on Congress 2023, as well as discussing the IBMS Long Term Biomedical Scientist Workforce Plan which was launched at the event, and also the IBMS’s work in lobbying and on equality, diversion and inclusivity.

The NHS has delivered on its ambition to roll out 10,000 virtual ward beds by the end of September, new figures show, with more than 240,000 patients treated on virtual wards.

The Delivery Group is officially launching its brand-new medical division - TDG Medical - at this year’s Lab Innovations show, leveraging its successes in providing a one-stop shop range across domestic and international e-commerce and mail services.

International Imaging Congress 2023 is coming to London Olympia on 31 October – 1 November, giving visitors the chance to shape and inspire their learning with insights and expertise from leading experts, as they share their visions for the future of medical imaging, diagnostic oncology, and digital pathology.

The London Clinic has completed a two-year, £4 million refit and redesign of its in-house blood sciences pathology laboratory, which now boasts gold-standard equipment. The use of ground-breaking technology in the diagnosis of cancer conditions will enable a far greater volume of accurate tests to be processed, around the clock, seven days a week.

Cirdan has secured £2.3 million in new funding to expand business operations with the creation of up to 25 new jobs ahead of new contract wins. The company is growing its revenues with an expected 80%-plus year-on-year growth in 2024.

Digital pathology firm Paige has launched its new AppLab, a vendor-neutral digital pathology and AI marketplace that empowers pathology laboratories to easily bring AI into their diagnostic workflows to optimise routine practice.

Laboratory product manufacturer Starlab is expanding its green activities in keeping with its motto ‘Towards the sustainable laboratory’. The company is launching a green dialogue across Europe for two weeks from 16 - 27 October 2023 to include a series of webinars promoting sustainability in laboratories.

Three projects designed to build our understanding of viruses and how the immune system reacts to different challenges will share £25 million in new funding from UK Research and Innovation (UKRI). The ambitious research will inform the development of new, broader and longer-lasting vaccines.

Artificial intelligence (AI)-powered cancer diagnostics firm Ibex Medical Analytics, and pathology laboratory CorePlus have collaborated on over 10,000 diagnosed cases of cancer using Galen, Ibex's AI-powered diagnostics platform. In a significant boost to patient outcomes, pathologists used AI-driven insights from Galen to correct the diagnosis of over 150 patients.

StatLab Medical Products has signed a definitive agreement to purchase Waldemar Knittel Glasbearbeitungs, a German manufacturer of microscope slides and cover glass and provider of engineering consulting services to the broader glass manufacturing industry.

Owlstone Medical has announced the recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1. The trial has been designed to support development of a breath test to address the unmet clinical need for more effective early detection of lung cancer through the screening of high-risk asymptomatic individuals.

Cambridge-based EDX Medical Group is developing a new generation of rapid healthcare tests capable of detecting and characterising a wide range of diseases within minutes. The new, miniaturised tests are expected to enable the identification of up to 10 disease markers simultaneously.

Patients across the country will benefit from a £30 million government investment in innovative medical technology which will help ease pressures on the NHS this winter and could include the expansion of 3D checks that speed up cancer tests and novel logistics solutions such as the use of drones.